These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36574181)

  • 21. Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort.
    Neuenschwander R; Hebeisen M; Micheroli R; Bürki K; Exer P; Niedermann K; Nissen MJ; Scherer A; Ciurea A
    Arthritis Res Ther; 2020 Oct; 22(1):233. PubMed ID: 33036663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study.
    Boel A; van Lunteren M; López-Medina C; Sieper J; van der Heijde D; van Gaalen FA
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35301267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT.
    Braun J; Blanco R; Marzo-Ortega H; Gensler LS; van den Bosch F; Hall S; Kameda H; Poddubnyy D; van de Sande M; Wiksten AS; Porter BO; Shete A; Richards HB; Haemmerle S; Deodhar A
    Arthritis Res Ther; 2021 Sep; 23(1):231. PubMed ID: 34481517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment.
    Vallier M; Segurens B; Larsonneur E; Meyer V; Ferreira S; Caloustian C; Deleuze JF; Dougados M; Chamaillard M; Miceli-Richard C
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36963782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
    Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
    Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study.
    Ziade N; Abi Karam G; Merheb G; Mallak I; Irani L; Alam E; Messaykeh J; Menassa J; Mroue' K; Uthman I; Masri AF; Ghorra P; Witte T; Baraliakos X
    Int J Rheum Dis; 2019 Apr; 22(4):708-714. PubMed ID: 30729696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort.
    van Lunteren M; Sepriano A; Landewé R; Sieper J; Rudwaleit M; van der Heijde D; van Gaalen F
    Arthritis Res Ther; 2018 Aug; 20(1):166. PubMed ID: 30075809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B27, axial spondyloarthritis and survival.
    Li Z; Khan MK; van der Linden SM; Winkens B; Villiger PM; Baumberger H; van Zandwijk H; Khan MA; Brown MA
    Ann Rheum Dis; 2023 Dec; 82(12):1558-1567. PubMed ID: 37679034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
    van Lunteren M; van der Heijde D; Sepriano A; Berg IJ; Dougados M; Gossec L; Jacobsson L; Ramonda R; Rudwaleit M; Sieper J; Landewé R; van Gaalen FA
    Rheumatology (Oxford); 2019 Sep; 58(9):1649-1654. PubMed ID: 30938446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.
    Ørnbjerg LM; Rugbjerg K; Georgiadis S; Rasmussen SH; Lindström U; Pavelka K; Yilmaz N; Favalli EG; Nissen MJ; Michelsen B; Vieira-Sousa E; Jones GT; Ionescu R; Relas H; Sanchez-Piedra C; Tomšič M; Geirsson AJ; van der Horst-Bruinsma I; Askling J; Loft AG; Nekvindova L; Direskeneli H; Iannone F; Ciurea A; Fagerli KM; Santos MJ; Macfarlane GJ; Codreanu C; Eklund K; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Rusman T; Østergaard M; Hetland ML
    J Rheumatol; 2023 Aug; 50(8):1009-1019. PubMed ID: 36455943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort.
    Pina Vegas L; Sbidian E; Wendling D; Goupille P; Ferkal S; Le Corvoisier P; Ghaleh B; Luciani A; Claudepierre P
    Rheumatology (Oxford); 2022 Apr; 61(4):1487-1495. PubMed ID: 34270707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis.
    Krabbe S; Glintborg B; Østergaard M; Hetland ML
    Scand J Rheumatol; 2019 Mar; 48(2):128-132. PubMed ID: 30102111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of HLA-B27-positive enthesitis/spondylitis-related arthritis in Senegal, West Africa.
    Sabounji MM; Ndiaye A; Diallo S
    Pediatr Rheumatol Online J; 2024 Feb; 22(1):31. PubMed ID: 38424655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study.
    Chaudhary H; López-Medina C; Khan MA; Dougados M; Magrey M
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37491128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis.
    Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; van der Horst-Bruinsma I; Loft AG; Möller B; Mann H; Conti F; Yildirim Cetin G; Relas H; Michelsen B; Avila Ribeiro P; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson ÁJ; Askling J; Glintborg B; Lindström U
    Rheumatology (Oxford); 2022 Nov; 61(12):4741-4751. PubMed ID: 35323903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol.
    Maksymowych WP; Kumke T; Auteri SE; Hoepken B; Bauer L; Rudwaleit M
    Arthritis Res Ther; 2021 Oct; 23(1):274. PubMed ID: 34715908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of remission in people with axial spondyloarthritis: A systematic literature review.
    Pinto AS; Farisogullari B; Machado PM
    Semin Arthritis Rheum; 2022 Oct; 56():152078. PubMed ID: 35944350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.
    Ciurea A; Scherer A; Weber U; Exer P; Bernhard J; Tamborrini G; Riek M; Müller RB; Weiss B; Nissen MJ; Kissling R; Michel BA; Finckh A;
    Ann Rheum Dis; 2016 Mar; 75(3):532-9. PubMed ID: 25667205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of HLA-B27 in Argentinian Axial Spondyloarthritis Patients.
    García-Salinas R; Ruta S; Chichande JT; Magri S
    J Clin Rheumatol; 2022 Mar; 28(2):e619-e622. PubMed ID: 34145202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.